Eric Sweet-Cordero

24PUBLICATIONS
195CO-AUTHORS
Predictive and prognostic markersSolid tumoursEnvironmentally sustainable engineeringHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Oct 20, 2026
Dysregulated AKT signaling reprograms osteosarcoma to drive selective reliance on EP300.

|Oct 14, 2026
PAX3::FOXO1 and the INO80 complex sustain replication fork progression in fusion positive rhabdomyosarcoma.

|Aug 27, 2026
SNHG family lncRNAs promote Ewing sarcoma cell fitness through intronic snoRNA-guided rRNA modifications.

|Mar 18, 2026
Tabular foundation model predicts alternative lengthening of telomeres (ALT) and identifies SMARCAL1 as a target in ALT-driven cancers.

D Bennett, M Wierdl, S Chakraborty

|Mar 11, 2026
FET Fusion Oncoproteins Disrupt Physiologic DNA Repair and Create a Targetable Opportunity for ATR Inhibitor Therapy.

Daniel E Gracilla, Shruti Menon, Marcus R Breese

|Oct 02, 2025
Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.

Eunice López-Fuentes, Andrew S Clugston, Alex G Lee

Pageof 4

Frequent Collaborators

5 joint publications

Stanley G Leung

5 joint publications

Leanne C Sayles

4 joint publications

Marcus R Breese

4 joint publications

Alex G Lee